Tongliao Pharmaceutical

Tongliao Pharmaceutical Co., Ltd. is a well-established Chinese pharmaceutical company based in Inner Mongolia and a core subsidiary of Inner Mongolia Furui Medical Science Co., Ltd. The company specializes in the research, development, and large-scale manufacturing of Traditional Chinese Medicine (TCM) and chemical pharmaceuticals, with a primary therapeutic focus on hepatology. Its flagship product, Compound Biejia Ruangan Tablets, is a leading TCM treatment for liver fibrosis and cirrhosis in the Chinese market. Tongliao Pharmaceutical operates multiple GMP-certified production lines for various dosage forms, including tablets, capsules, and granules. By integrating traditional herbal formulations with modern pharmaceutical technology, the company serves as a critical production hub for its parent group's integrated liver disease management strategy.